Ojeleye Oluwagbemileke, Avery Anthony J, Boyd Matthew J
Division of Social Research in Medicines and Health, School of Pharmacy, University of Nottingham, Nottingham, UK.
Br J Clin Pharmacol. 2014 Aug;78(2):401-9. doi: 10.1111/bcp.12347.
To evaluate the ability of electronic patient medication record (ePMR) systems used in community pharmacies in England to detect and alert users about clinical hazards, errors and other safety problems.
Between September 2012 and November 2012, direct on-site observational data about the performance of ePMR systems were collected from nine sites. Twenty-eight scenarios were developed by consensus agreement between a general practitioner and two community pharmacists. Each scenario was entered into the ePMR system, and the results obtained from the assessment of six unique systems in nine sites, in terms of the presence or absence of an alert, were recorded onto a prespecified form.
None of the systems produced the correct responses for all of the 28 scenarios tested. Only two systems provided an alert to penicillin sensitivity. No dose or frequency check was observed when processing a prescription for methotrexate. One system did not warn about nonsuitability of aspirin prescribed to a child of 14 years of age. In another system, it was not possible to record a patient's pregnancy status. None of the six systems provided any warning for diclofenac overdose, high initiation dose of morphine sulfate or significant dose increase. Only one of the systems did not produce any spurious alerts.
The performance of the ePMR systems tested was variable and suboptimal. The findings suggest the need for minimum specifications and standards for ePMR systems to ensure consistency of performance.
评估英国社区药房使用的电子患者用药记录(ePMR)系统检测并提醒用户注意临床风险、差错及其他安全问题的能力。
在2012年9月至2012年11月期间,从9个地点收集了关于ePMR系统性能的直接现场观察数据。由一名全科医生和两名社区药剂师经协商一致制定了28个场景。将每个场景输入ePMR系统,并将从9个地点的6个不同系统评估中获得的关于是否有警报的结果记录在预先指定的表格上。
没有一个系统对所有28个测试场景都给出正确响应。只有两个系统对青霉素敏感性发出了警报。处理甲氨蝶呤处方时未进行剂量或频率检查。有一个系统未对给一名14岁儿童开具阿司匹林的不适用性发出警告。在另一个系统中,无法记录患者的妊娠状态。六个系统中没有一个对双氯芬酸过量、硫酸吗啡高起始剂量或显著剂量增加发出任何警告。只有一个系统未产生任何虚假警报。
所测试的ePMR系统的性能参差不齐且未达最佳。研究结果表明需要为ePMR系统制定最低规格和标准,以确保性能的一致性。